100% organically grown Ipecac Alkaloids of Superior Quality

Close collaboration between our team of agri-engineers and in house laboratory infrastructure generates a 100% organically farmed crop with an average Ipecac alkaloid percentage of 5%.
Full supply chain logistics are managed by our Customer service teams in Costa Rica, the US and the Netherlands.
This includes - off site transport, - international export services, - alkaloid extraction, - laboratory quality control, - customised packaging and final delivery to any client facility worldwide.
Excellence starts in our Roots!

Raicilla is considered a medicinal herb and has been used to treat various ailments since the 1760’s. The active medical agents, emetine, cephaeline, psychotrine and ipecoside, known as Ipecac alkaloids, are extracted from the vegetative material and the root system.
Ipecac has a long history of being a widely used pharmaceutical plant in the United States of America and Europe as an emetic, treatment for parasitic diseases and to treat coughs and bronchitis.
In the last 3 years, novel drug delivery systems (NDDS) for herbal constituents with far more sophisticated technology have entered the market. NDDS are Nano technology based and allow for more reliable growth techniques and consistent extraction quality. This enabled a “repositioning”of Ipecac alkaloids as a next generation agent for treatments that fight Malaria, Cancer and HIV.
Pharmalead and JuicyFields Partner Up
Pharmalead announces a partnership with Germany-based JuicyFields. In close cooperation with JuicyFields and Partners, Pharmalead will shift its activities to the market of medical cannabis. The ambitious project will be placed under the supervision of Thomas Walker who owns an impressive record of projects successfully executed for JuicyFields. About JuicyFieldsJuicyFields…
Next generation medical research

Next generation medical research on Emetine-centered synergistic treatment trials at early detection stages
Research has shown that the monoterpenes found in botanicals like Ipecac can alter very small masses of non-detectable early cancer cells. In this way they prevent cancer at the progression stage. This research suggests that the monoterpenes are an example of a potential new class of anticancer agents with a value proposition that bridges prevention and therapy.